Many patients are finding relief from treatment-resistant depression, PTSD, and other chronic illnesses by utilizing ketamine to improve their symptoms. Now, with the FDA-approved form of ketamine (Spravato, also known as esketamine) hitting the market, many consumers are curious about the difference between the two.

Ketamine therapy has increasingly become a promising option for individuals seeking effective mental health treatment, especially for conditions like treatment-resistant depression (TRD). Ketamine is one of the only anesthesia medications that does not suppress the body’s ability to protect its airway, suppress the respiratory system or cardiovascular system. Its potential benefits for individuals with kidney issues and minimal interactions with other medications make it an ideal option for many.

For millions of people worldwide, depression is a debilitating condition that disrupts daily life and diminishes joy. While many respond positively to traditional treatments such as SSRIs (Selective Serotonin Reuptake Inhibitors) and SNRIs (Serotonin-Norepinephrine Reuptake Inhibitors), others find themselves in a frustrating position—medications and therapies that work for others simply don't bring relief. These individuals may be suffering from Treatment-Resistant Depression (TRD), a more complex form of depression.

Pain is a universal experience, yet it can be incredibly complex and varied. Understanding pain, its origins, and how it can be managed is crucial for anyone seeking relief.

Ketamine has long been stigmatized, often associated with recreational abuse and illegal activities. However, recent scientific research and clinical practices are revealing its transformative potential in mental health treatment.

A diverse range of psychedelic substances has been explored in clinical research programs for their potential impact on a range of mental health conditions. These conditions include severe treatment-resistant depression, terminal-illness related depression, ALS, end-of-life anxiety, severe treatment-resistant anxiety, generalized anxiety, and PTSD. Among the substances being researched are LSD, MDMA, and psilocybin.

In light of Matthew Perry's tragic death, the conversation surrounding ketamine therapy has intensified, underscoring the need for a deeper understanding of its therapeutic applications and safety considerations.

Are you considering ketamine infusions for mental health treatment or maybe you have already reaped the positive effects from them, but concerned about the financial aspect? One of the most common questions we get asked is “does my insurance cover ketamine infusions?”

It can be frustrating to finally find something that works for your treatment resistant depression, anxiety or neuropathic pain that insurance may not cover. 

While some medical clinics continue to look for ways to thrive or survive since the COVID-19 pandemic, some clinics have chosen a new offering to tack on to their existing niche or specialty that is adding new patients and new revenue to their business model.